Experiments for taxon Glycyrrhiza species (FABACEAE)

Experiments (180 results)

Filters
Worktypes (35)
55
46
39
38
28
22
20
20
20
17
14
12
12
8
7
7
5
5
5
4
4
3
2
2
2
2
1
1
1
1
1
1
1
1
1
No match
Pharmacology (58)
8
6
5
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
71
No match
Compounds (55)
9
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
99
No match
Organisms (50)
17
15
15
10
10
9
8
7
7
5
5
5
5
5
5
4
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
180 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
988514
PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LIQUIRITIGENIN,ISO:
107674
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOPYRANOCOUMARIN
911532
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
161577
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
MEDICARPIN,(-):
952879
PHARMACOLOGY OF EXTRACT - IN VIVO
PLASMA BILIRUBIN DECREASE
Glycyrrhiza species (FABACEAE)
1217381
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
561445
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GANCAONIN S
161570
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
FICIFOLINOL,1-METHOXY:
1216070
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
1216069
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
UTERINE RELAXATION EFFECT
Glycyrrhiza species (FABACEAE)
1061671
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Glycyrrhiza species (FABACEAE)
107679
PHARMACOLOGY OF COMPOUND - IN VITRO
XANTHINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
LICOCOUMARONE
109890
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
FICIFOLINOL,1-METHOXY:
1271934
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Glycyrrhiza species (FABACEAE)
1194684
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
BLOOD VISCOSITY DECREASED
Glycyrrhiza species (FABACEAE)
161581
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOCHALCONE B
1170301
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Glycyrrhiza species (FABACEAE)
161574
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOISOFLAVAN A
937312
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Glycyrrhiza species (FABACEAE)
118636
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
GLICORICONE
105056
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN I
1028172
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZA TRITERPENE,DIGLURONYL:
514281
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Glycyrrhiza species (FABACEAE)
1216075
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Glycyrrhiza species (FABACEAE)
161580
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
FORMONONETIN
107675
PHARMACOLOGY OF COMPOUND - IN VITRO
XANTHINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
LICOPYRANOCOUMARIN
317172
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYCHEMICAL VARIATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Glycyrrhiza species (FABACEAE)
107671
PHARMACOLOGY OF COMPOUND - IN VITRO
XANTHINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
LICOARYLCOUMARIN
161585
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
FLAVONE,ISO: 7-HYDROXY-4'-8-DIMETHOXY:
118633
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Glycyrrhiza species (FABACEAE)
LICOFURANONE
109894
ISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICORICIDIN,(+):PHASEOLLIDIN,1-O-METHYL: (-):LICOFLAVONOLGLYCYROL,ISO:KUMATAKENINGLYCYROL,3-O-METHYL:MEDICARPIN,(-):GANCAONIN ILICORICIDIN,7-O-METHYL: (+):
1170300
PHARMACOLOGY OF EXTRACT - IN VIVO
CNS DEPRESSANT ACTIVITY
Glycyrrhiza species (FABACEAE)
1210952
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
DEATH
Glycyrrhiza species (FABACEAE)
1216064
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
911540
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
1129825
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
PROTECTIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
1216071
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
911536
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
1217385
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
161578
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
NARINGENIN
952876
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
1170297
PHARMACOLOGY OF EXTRACT - IN VIVO
BARBITURATE POTENTIATION
Glycyrrhiza species (FABACEAE)
911543
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Glycyrrhiza species (FABACEAE)
1170298
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTHERMIC ACTIVITY
Glycyrrhiza species (FABACEAE)
544926
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Glycyrrhiza species (FABACEAE)
1217380
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
1186203
ISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHETINIC ACID
911539
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
774944
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
774941
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Glycyrrhiza species (FABACEAE)
105060
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KUMATAKENIN
1271933
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPYRETIC ACTIVITY
Glycyrrhiza species (FABACEAE)
911533
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
799886
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OFREVIEW OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
161582
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOCHALCONE A
161571
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN X
1217378
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTITUSSIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
105059
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICORICIDIN
952878
PHARMACOLOGY OF EXTRACT - IN VIVO
ALKALINE PHOSPHATASE STIMULATION
Glycyrrhiza species (FABACEAE)
1216068
PHARMACOLOGY OF EXTRACT - IN VITRO
PEPSIN INHIBITION
Glycyrrhiza species (FABACEAE)
1129828
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
TOXICITY ASSESSMENT(QUANTITATIVE)
Glycyrrhiza species (FABACEAE)
407591
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Glycyrrhiza species (FABACEAE)
LICOFLAVONOL
1216076
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIEMETIC ACTIVITY
Glycyrrhiza species (FABACEAE)
317174
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYCHEMICAL VARIATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
1210951
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Glycyrrhiza species (FABACEAE)
1210954
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
NEPHROTOXIC ACTIVITY
Glycyrrhiza species (FABACEAE)
911537
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Glycyrrhiza species (FABACEAE)
1216065
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Glycyrrhiza species (FABACEAE)
988517
ISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLABROL
109893
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
LICOISOFLAVONE B,SEMI:
161575
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KANZONOL F
107676
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KAEMPFEROL-3-O-METHYL ETHER
317171
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYCHEMICAL VARIATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Glycyrrhiza species (FABACEAE)
105055
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN H
514282
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Glycyrrhiza species (FABACEAE)
1216072
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Glycyrrhiza species (FABACEAE)
767073
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
1293685
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR INHIBITION
Glycyrrhiza species (FABACEAE)
1217384
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
810039
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
107670
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
LICOARYLCOUMARIN
1303739
REVIEW OF
ANTIVIRAL ACTIVITY
Glycyrrhiza species (FABACEAE)
118639
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
ECHINATIN
937313
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Glycyrrhiza species (FABACEAE)
1271937
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERTENSIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
1293687
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-6 RELEASE INHIBITION
Glycyrrhiza species (FABACEAE)
985655
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GLYCYRIN
109892
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
LICORIPHENONE
326259
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
118637
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GENISTEIN
161583
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KANZONOL I
105061
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYROL,5-O-METHYL:
937314
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Glycyrrhiza species (FABACEAE)
161572
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN Z
105058
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCORRECTION OF STRUCTUREQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYROL
161569
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN Y
20365
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
UTERINE STIMULANT EFFECT
Glycyrrhiza species (FABACEAE)
774942
PHARMACOLOGY OF EXTRACT - IN VIVO
SLEEP TIME INCREASED
Glycyrrhiza species (FABACEAE)
1129824
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Glycyrrhiza species (FABACEAE)
911534
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
688845
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Glycyrrhiza species (FABACEAE)
952877
PHARMACOLOGY OF EXTRACT - IN VIVO
LACTATE DEHYDROGENASE STIMULATION
Glycyrrhiza species (FABACEAE)
1271932
MEDICINAL FOLKLORE REPORTED FOR
ANTIPYRETIC ACTIVITY
Glycyrrhiza species (FABACEAE)
118631
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOPYRANOCOUMARIN
407592
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KUMATAKENINLICORICONEGLYCYROL
909416
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT POSITIVE
Glycyrrhiza species (FABACEAE)
561448
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Glycyrrhiza species (FABACEAE)
GANCAONIN S
514283
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Glycyrrhiza species (FABACEAE)
1271936
PHARMACOLOGY OF EXTRACT - IN VIVO
CARDIOTOXIC ACTIVITY
Glycyrrhiza species (FABACEAE)
107677
PHARMACOLOGY OF COMPOUND - IN VITRO
XANTHINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
KAEMPFEROL-3-O-METHYL ETHER
911538
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
1293686
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Glycyrrhiza species (FABACEAE)
118638
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
GENISTEIN
909415
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT NEGATIVE
Glycyrrhiza species (FABACEAE)
1217379
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
HYPOTENSIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
1216062
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
339190
PHARMACEUTICAL ANALYSIS OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Glycyrrhiza species (FABACEAE)
GLYCYRRHETINIC ACIDLIQUIRITIGENIN,ISO:LIQUIRITIGENIN
1061672
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Glycyrrhiza species (FABACEAE)
988518
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Glycyrrhiza species (FABACEAE)
LICOISOFLAVANONELICOISOFLAVONE B
1129827
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
TOXICITY ASSESSMENT(QUANTITATIVE)
Glycyrrhiza species (FABACEAE)
988516
PMR SPECTRUM REPORTEDCOMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
ECHINATIN
1170302
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Glycyrrhiza species (FABACEAE)
1216073
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Glycyrrhiza species (FABACEAE)
379118
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Glycyrrhiza species (FABACEAE)
1210950
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Glycyrrhiza species (FABACEAE)
561447
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GANCAONIN S
1170299
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERTHERMIC EFFECT
Glycyrrhiza species (FABACEAE)
105053
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN F
1216066
PHARMACOLOGY OF EXTRACT - IN VIVO
INTESTINAL MOTILITY INHIBITION
Glycyrrhiza species (FABACEAE)
450849
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Glycyrrhiza species (FABACEAE)
118634
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
LICOFURANONE
161576
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
KANZONOL B
774945
PHARMACOLOGY OF EXTRACT - IN VIVO
LACTATE DEHYDROGENASE INHIBITION
Glycyrrhiza species (FABACEAE)
739594
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
1217383
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
839987
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
911541
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
105057
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCORRECTION OF STRUCTUREQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
CHYCYROL,ISO:
405084
PHARMACOLOGY OF EXTRACT - IN HUMANS
GRAS STATUS
Glycyrrhiza species (FABACEAE)
911535
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Glycyrrhiza species (FABACEAE)
1217382
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SMOOTH MUSCLE RELAXANT ACTIVITY
Glycyrrhiza species (FABACEAE)
161584
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYROL
325665
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHETINIC ACID
107673
PHARMACOLOGY OF COMPOUND - IN VITRO
XANTHINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
GLISOFLAVONE
109891
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
ANGUSTONE A,ISO:
774943
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Glycyrrhiza species (FABACEAE)
105062
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICORICONE
107678
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICOCOUMARONE
1271938
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Glycyrrhiza species (FABACEAE)
885007
UV SPECTRUM GIVEN FORSTRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCORRECTION OF STRUCTUREQUANTITATIVE DATACD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
LICORICIDIN
118632
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION
Glycyrrhiza species (FABACEAE)
LICOPYRANOCOUMARIN
1216074
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Glycyrrhiza species (FABACEAE)
911531
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPYRETIC ACTIVITY
Glycyrrhiza species (FABACEAE)
161573
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LICORICIDIN
1186204
PHARMACOLOGY OF COMPOUND - IN VITRO
CORTICOID 5-BETA REDUCTASE INHIBITION
Glycyrrhiza species (FABACEAE)
GLYCYRRHETINIC ACID
688844
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Glycyrrhiza species (FABACEAE)
988515
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
FLAVONE,4'-7-DIHYDROXY:FORMONONETIN
118635
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Glycyrrhiza species (FABACEAE)
GLICORICONE
1170303
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Glycyrrhiza species (FABACEAE)
1271935
PHARMACOLOGY OF EXTRACT - IN VIVO
CHRONOTROPIC EFFECT POSITIVE
Glycyrrhiza species (FABACEAE)
379119
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Glycyrrhiza species (FABACEAE)
911529
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Glycyrrhiza species (FABACEAE)
1210953
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
DEATH
Glycyrrhiza species (FABACEAE)
1216063
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Glycyrrhiza species (FABACEAE)
866525
SPECTROPHOTOMETRIC ASSAY OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
952875
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-OXALOACETATE-TRANSAMINASE STIMULATION
Glycyrrhiza species (FABACEAE)
862906
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZIN
317173
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYCHEMICAL VARIATIONIDENTIFICATION OFQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Glycyrrhiza species (FABACEAE)
1129826
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTILEUKOPENIC ACTIVITY
Glycyrrhiza species (FABACEAE)
154939
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED
Glycyrrhiza species (FABACEAE)
GANCAONIN W
407590
IDENTIFICATION IN BY TLC
Glycyrrhiza species (FABACEAE)
LICOFLAVONOLGLYCYROL,ISO:KUMATAKENINLICORICONEGLYCYROL
561446
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ATP-ASE(NA+/K+) INHIBITION
Glycyrrhiza species (FABACEAE)
GANCAONIN S
1216067
PHARMACOLOGY OF EXTRACT - IN VIVO
GASTRIC SECRETORY INHIBITION
Glycyrrhiza species (FABACEAE)
105054
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GANCAONIN G
1028173
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Glycyrrhiza species (FABACEAE)
GLYCYRRHIZA TRITERPENE,DIGLURONYL:
911542
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Glycyrrhiza species (FABACEAE)
107672
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Glycyrrhiza species (FABACEAE)
GLISOFLAVONE
911530
PHARMACOLOGY OF EXTRACT - IN VIVO
BARBITURATE POTENTIATION
Glycyrrhiza species (FABACEAE)
161579
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
LIQUIRITIGENIN,ISO:
514284
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Glycyrrhiza species (FABACEAE)